What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
Focused on gene and cellular therapies, this biotech firm reported a notable insider sale amid a year of rapid share price gains.
Overview
On July 1, 2026, Precigen (NASDAQ:PGEN) Chief Financial Officer Harry Thomasian Jr. reported the sale of 200,000 shares of common stock in multiple open-market transactions between June 29 and July 1, 2026, as detailed in the SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($5.57); post-transaction value based on July 1, 2026 market close.
Details
* 1-year price change calculated using July 1, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.